Nimotuzumab in Combination With Chemoradiation for Nasopharyngeal Cancer

Clinical trial NCT01074021 · UNKNOWN

Trial details

NCT number: NCT01074021
Sponsor: Biotech Pharmaceutical Co., Ltd.
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Nasopharyngeal Cancer

Start date: 2009-10-01
Primary completion: 2016-05-01
Enrollment: 480

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.